General

Why Is Cintas Stock Gaining Thursday?

Why Is Cintas Stock Gaining Thursday?

White House Readies Drug Price Deals With AbbVie, Novartis, Roche

White House Readies Drug Price Deals With AbbVie, Novartis, Roche

Obesity Drugs Like GLP-1 Are Impacting Alcohol Consumption, Darden Flags

Obesity Drugs Like GLP-1 Are Impacting Alcohol Consumption, Darden Flags

White House Readies Drug Price Deals With AbbVie, Novartis, Roche

White House Readies Drug Price Deals With AbbVie, Novartis, Roche

Obesity Drugs Like GLP-1 Are Impacting Alcohol Consumption, Darden Flags

Obesity Drugs Like GLP-1 Are Impacting Alcohol Consumption, Darden Flags

Medtech Integer Could Be More Valuable As A Private Company - Activist Investor Urges Strategic Review

Medtech Integer Could Be More Valuable As A Private Company - Activist Investor Urges Strategic Review

Trump Media Makes $6 Billion Fusion Power Play To Fuel AI Future (UPDATED)

Trump Media Makes $6 Billion Fusion Power Play To Fuel AI Future (UPDATED)

Medtech Integer Could Be More Valuable As A Private Company - Activist Investor Urges Strategic Review

Medtech Integer Could Be More Valuable As A Private Company - Activist Investor Urges Strategic Review

Trump Media Makes $6 Billion Fusion Power Play To Fuel AI Future (UPDATED)

Trump Media Makes $6 Billion Fusion Power Play To Fuel AI Future (UPDATED)

Birkenstock Stretches To Meet Demand, But Tariffs, Currency Leave A Sore Spot

Birkenstock Stretches To Meet Demand, But Tariffs, Currency Leave A Sore Spot

Why Is Small Cap Sol-Gel Tech Stock Falling Today?

Why Is Small Cap Sol-Gel Tech Stock Falling Today?

General Recent News

Oracle's $10 Billion OpenAI Data Center Bet Faces Fresh Doubts After Financing Partner Pulls Out — Is The Deal In Jeopardy?

Oracle's $10 Billion OpenAI Data Center Bet Faces Fresh Doubts After Financing Partner Pulls Out — Is The Deal In Jeopardy?

Blue Owl Capital's decision to step away from financing an Oracle-backed (NYSE: ORCL) AI data center has become a fresh flashpoint for investors already on edge about the financial architecture behind the AI infrastructure boom.

Instacart Stock Drops Over 6% In Thursday Pre-Market: What's Going On?

Instacart Stock Drops Over 6% In Thursday Pre-Market: What's Going On?

Shares of Instacart Inc. (NYSE: CART) declined 6.64% in pre-market trading on Thursday, after a report that the Federal Trade Commission (FTC) is launching a probe into its AI-based pricing tool.

Starlink In Tesla Vehicles? New Patent Filing Showcases Possibility Of Satellite Internet Connectivity

Starlink In Tesla Vehicles? New Patent Filing Showcases Possibility Of Satellite Internet Connectivity

A new Tesla filing reveals plans for RF transparent car roofs that could integrate with Starlink connectivity.

Bryan Johnson Says Human Immortality Could Be Possible By 2039 Thanks To AI Boom: 'Absolutely Insane Moment...'

Bryan Johnson Says Human Immortality Could Be Possible By 2039 Thanks To AI Boom: 'Absolutely Insane Moment...'

Bryan Johnson predicts immortality achievable in 14 years, but warns of risks in using AI and biotech. He says anti-aging therapies are still unsafe.

Joby Aviation To Double US Manufacturing Capacity By 2027 Amid Air Taxi Push

Joby Aviation To Double US Manufacturing Capacity By 2027 Amid Air Taxi Push

Joby Aviation Inc. (NYSE: JOBY) unveiled plans on Wednesday to double its manufacturing capacity in the United States, in a move that will support the production of four aircraft per month over the next two years.

Elliott Management Takes $1 Billion Stake In Lululemon, Proposes Former Ralph Lauren Executive As New CEO: Report

Elliott Management Takes $1 Billion Stake In Lululemon, Proposes Former Ralph Lauren Executive As New CEO: Report

Activist investor Elliott Investment Management has reportedly acquired an over $1 billion stake in Lululemon Athletica (NASDAQ: LULU) and is proposing a new CEO to help the company recover from its recent struggles.

Medline (MDLN) Stock Falls In After-Hours Trading Following 41% IPO Surge

Medline (MDLN) Stock Falls In After-Hours Trading Following 41% IPO Surge

Medline shares fell in after-hours trading following its upsized IPO pricing at $29 per share.

Gene Munster Says If It Was A Basketball Game Google's Waymo Would Be Up 50-2 Against Elon Musk's Tesla, But He Has A 'Spoiler Alert'

Gene Munster Says If It Was A Basketball Game Google's Waymo Would Be Up 50-2 Against Elon Musk's Tesla, But He Has A 'Spoiler Alert'

Fund manager and prominent tech analyst Gene Munster said Alphabet Inc.'s (NASDAQ: GOOG) Waymo is firmly in the lead against rival Tesla Inc. (NASDAQ: TSLA) in the U.S. robotaxi market, while noting that the race was still in its early stages, with plenty of time to close this gap.

Cigna Offers Cleaner Growth Than Other Health Insurers, Says Analyst

Cigna Offers Cleaner Growth Than Other Health Insurers, Says Analyst

BofA outlines risks and upside for managed care stocks, favoring Cigna and Alignment while flagging Medicare and Medicaid uncertainty.

Why Is Inspirato Stock Gaining Today?

Why Is Inspirato Stock Gaining Today?

Inspirato shares surged after Exclusive Investments agreed to buy the company in an all-cash deal at a premium, taking it private in early 2026.

Saia Navigates Trucking Turbulence With Clear 2026 Upside, Analyst Says

Saia Navigates Trucking Turbulence With Clear 2026 Upside, Analyst Says

Saia Inc (SAIA) stock fell as investors weighed mixed Q4 freight trends against confidence in long-term national expansion strategy.

Soligenix Psoriasis Trial Extension Shows Better Outcomes With New Gel

Soligenix Psoriasis Trial Extension Shows Better Outcomes With New Gel

Soligenix reports positive Phase 2a extension results for SGX302 gel in psoriasis, showing improved skin scores and strong tolerability.

Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data?

Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data?

Processa Pharmaceuticals' stock jumps after Phase 2 data show higher capecitabine exposure without added toxicity in metastatic breast cancer patients.